Published in PLoS One on August 14, 2014
Genome-Wide Association Study Identifies Novel Susceptibility Genes Associated with Coronary Artery Aneurysm Formation in Kawasaki Disease. PLoS One (2016) 0.77
The effect of FcγRIIA and FcγRIIB on coronary artery lesion formation and intravenous immunoglobulin treatment responses in children with Kawasaki disease. Oncotarget (2016) 0.76
Association of PECAM-1 Gene Polymorphisms with Kawasaki Disease in Chinese Children. Dis Markers (2017) 0.75
The association of interleukin-31 polymorphisms with interleukin-31 serum levels and risk of systemic lupus erythematosus. Rheumatol Int (2016) 0.75
A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan. Pediatrics (1974) 9.97
The relationship of eosinophilia to intravenous immunoglobulin treatment failure in Kawasaki disease. Pediatr Allergy Immunol (2007) 2.81
Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice. Nat Immunol (2004) 2.65
Prediction of intravenous immunoglobulin unresponsiveness in patients with Kawasaki disease. Circulation (2006) 2.56
IL-31: a new link between T cells and pruritus in atopic skin inflammation. J Allergy Clin Immunol (2006) 2.39
Outcome of coronary artery aneurysms after Kawasaki disease. J Pediatr (1992) 2.03
A predictive instrument for coronary artery aneurysms in Kawasaki disease. US Multicenter Kawasaki Disease Study Group. Am J Cardiol (1998) 1.91
The effect of Kawasaki disease on childhood allergies - a sibling control study. Pediatr Allergy Immunol (2011) 1.62
Kawasaki disease. Pediatr Clin North Am (1995) 1.35
Leukocyte counts and coronary heart disease in a Japanese cohort. Am J Epidemiol (1982) 1.32
Correlation of IL-31 serum levels with severity of atopic dermatitis. J Allergy Clin Immunol (2008) 1.28
Kawasaki disease: an update on diagnosis and treatment. Pediatr Neonatol (2012) 1.25
Tendency toward atopy in Kawasaki disease. Eur J Pediatr (1997) 1.12
Eosinophilia and positive skin tests predict cardiovascular mortality in a general population sample followed for 30 years. Am J Epidemiol (1999) 1.08
Human IL-31 is induced by IL-4 and promotes TH2-driven inflammation. J Allergy Clin Immunol (2013) 1.03
Increased prevalence of atopic dermatitis in Kawasaki disease. Pediatr Infect Dis J (1988) 1.03
Activation of human eosinophils and epidermal keratinocytes by Th2 cytokine IL-31: implication for the immunopathogenesis of atopic dermatitis. Int Immunol (2010) 1.03
Evaluation of intravenous immunoglobulin resistance and coronary artery lesions in relation to Th1/Th2 cytokine profiles in patients with Kawasaki disease. Arthritis Rheum (2013) 1.01
Augmented TLR2 expression on monocytes in both human Kawasaki disease and a mouse model of coronary arteritis. PLoS One (2012) 0.94
Elevated gamma-glutamyltransferase concentrations in patients with acute Kawasaki disease. Pediatr Infect Dis J (1998) 0.91
Peripheral blood eosinophilia and eosinophil accumulation in coronary microvessels in acute Kawasaki disease. Pediatr Infect Dis J (2002) 0.90
Hospitalisation with infection, asthma and allergy in Kawasaki disease patients and their families: genealogical analysis using linked population data. PLoS One (2011) 0.86
Identifying Polymorphisms in IL-31 and Their Association with Susceptibility to Asthma. Korean J Pathol (2012) 0.85
Characterization of pollen antigen-induced IL-31 production by PBMCs in patients with allergic rhinitis. J Allergy Clin Immunol (2011) 0.83
TARC/CCL17 gene polymorphisms and expression associated with susceptibility and coronary artery aneurysm formation in Kawasaki disease. Pediatr Res (2013) 0.82
Role of IL-31 in regulation of Th2 cytokine levels in patients with nasal polyps. Eur Arch Otorhinolaryngol (2014) 0.81
Retrograde holodiastolic flow in the abdominal aorta detected by pulsed Doppler echocardiography in patients with Kawasaki disease. Eur J Pediatr (2000) 0.78
Comparison of the laboratory data between Kawasaki disease and enterovirus after intravenous immunoglobulin treatment. Pediatr Cardiol (2012) 0.77
Pachyman treatment improves CD4+CD25+ Treg counts and serum interleukin 4 and interferon γ levels in a mouse model of Kawasaki disease. Mol Med Rep (2012) 0.77